Dividend Growth of Shire PLC(SHPG)

Shire plc(SHPG) is having a Dividend Yield of 0.46% with the Annual cash Dividend per share of $0.8. Shire plc has a 5 year average dividend yield of 0.4% and the stock has a Indicated annual dividend of $0.8. Shire plc(SHPG) formally announced its most recent dividend on September 16, 2016 with a Dividend per share of $0.14. The new indicated annual dividend based on announced dividend per share is $0.8. The dividend yield based on the forward looking indicated annual dividend is 0.46%. Shire plc(SHPG) has the most recent dividend payout ratio of 0.06 with a 5-year average payout ratio of 0.07. The 5 year historical dividend growth of Shire plc(SHPG) is at the rate of 14.55% while the R-Squared dividend growth is 0.98. If the value of R-Square is close to one, it indicates a perfect fit and the higher value conforms to the regression line while data close to zero indicates the opposite.

Shire plc (NASDAQ:SHPG) rose 2.58% or 4.5 points on Thursday and made its way into the gainers of the day. After trading began at $181.91 the stock was seen hitting $182.5 as a peak level and $177.42 as the lowest level. The stock ended up at $178.7. The daily volume was measured at 2,067,030 shares. The 52-week high of the share price is $209.22 and the 52-week low is $150.055. The company has a market cap of $53,884 million. Shares of Shire plc rose by 4% in the last five trading days and 7.39% for the last 4 weeks. Shire plc has dropped 1.29% during the last 3-month period . Year-to-Date the stock performance stands at 4.88%.

Currently the company Insiders own 2% of Shire plc shares according to the proxy statements. Institutional Investors own 22.69% of Shire plc shares. Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.Shire PLC (ADR) was Initiated by Societe Generale to Buy on Dec 2, 2016.

Shire PLC (ADR) Last issued its quarterly earnings results on Feb 16, 2017. The company reported $3.37 EPS for the quarter, beating the analyst consensus estimate by $ 0.14. Analyst had a consensus of $3.23. The company had revenue of $3806.10 million for the quarter, compared to analysts expectations of $3761.42 million. The companys revenue was up 121.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.97 EPS.

Shire Pharmaceuticals Group plc is a specialty pharmaceutical company focused primarily on two therapeutic areas: central nervous system disorders and metabolic bone diseases. (press release)

Shire

Post Comment